pioglitazone (Actos) improves lipids better than rosiglitazone (Avandia)

August 2005

Reps will be touting new evidence that pioglitazone (Actos) improves lipids better than rosiglitazone (Avandia).

Both glitazones reduce A1C equally.

But pioglitazone seems better at lowering triglycerides and increasing HDL. Pioglitazone LOWERS triglycerides about 9% to 12%... rosiglitazone can INCREASE triglycerides up to 15%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote